Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News
  • Published:

Antibody offers hope for multiple sclerosis treatment

Promising phase III trial paves the way for alemtuzumab approval.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

References

  1. Coles, A. J. et al. New Engl. J. Med. 359, 1786-1801 (2008).

    Article  Google Scholar 

  2. Jones, J. L. et al. Brain 133, 2232-2247 (2010).

    Article  Google Scholar 

Download references

Authors

Related links

Related links

Related external links

CARE-MS

Genzyme

Sanofi

Rights and permissions

Reprints and permissions

About this article

Cite this article

Graham-Rowe, D. Antibody offers hope for multiple sclerosis treatment. Nature (2011). https://doi.org/10.1038/news.2011.609

Download citation

  • Published:

  • DOI: https://doi.org/10.1038/news.2011.609

Search

Quick links

Nature Briefing: Translational Research

Sign up for the Nature Briefing: Translational Research newsletter — top stories in biotechnology, drug discovery and pharma.

Get what matters in translational research, free to your inbox weekly. Sign up for Nature Briefing: Translational Research